The recent topic of "God Medicine" swept the whole network, which deeply reflected the long-standing chaos of the medical circle. Over the years, due to the advertising effect, people are full of trust in a large number of well-known drugs, but I don’t know if there are other things. Unscrupulous pharmaceutical companies and advertisers are happy, the medical circle and the drug public are deeply hated, and the state is also racking their brains. In addition to the "Shapu Aisi"-style advertising brainwashing medicine, there are still many "one-size-fits-all" drugs with poor efficacy, high cost and many clinical adverse reactions. We will call them "the god medicine" for the time being. . How to let the "God medicine" nowhere to consciously withdraw from the market? The country’s first force and the people’s response. In recent years, the state has continuously introduced new regulatory mechanisms, striving to effectively manage all kinds of undesirable phenomena in the pharmaceutical market and create a healthy living environment for the people. The "Shenzhen" chaos has also been included in the important regulatory section. Following the footsteps of the country, the drug "Shen medicine" database (assisted and key monitoring drug database) came into being. Focus on supervision, multiple “medicine drugs†are restricted, suspended, and banned Interestingly, in the multi-site auxiliary drug files, the words “universal medicine†and “monosodium glutamate†are often seen, which is undoubtedly the original source of the word “medicineâ€. Auxiliary medication refers to a drug that has clinically helped to increase the main therapeutic drug or affects the absorption, mechanism of action, metabolism of the main therapeutic drug to increase its efficacy, reduce toxic side effects; or contribute to the prevention of disease or dysfunction And therapeutic drugs. Auxiliary drugs are not guilty, and unprincipled, unreasonable use of irrationality is its original sin. The Health Planning Commission issued a notice of control fees, and the State Food and Drug Administration strengthened the supervision of the pharmaceutical market, and continuously issued policies and regulations to organize flight inspections, follow-up inspections, special supervision and sampling, etc., to strengthen monitoring and restrict the procurement of auxiliary medicines. Bureaus and hospitals have set up key monitoring drug catalogues and strengthened monitoring, restricting procurement, suspending and prohibiting use throughout the country. As early as July 2016, Inner Mongolia imposed a warning on medical institutions to prescribe prescriptions or inpatients with an unsuitable rate of adjuvant drug use exceeding 10%. It will be deactivated and will not be restored within the year; not long ago, a hospital in Sichuan Province will Shuxu Ning, Danshen Chuanxiong A large number of varieties such as azine and cerebroside carnosine were included in the key monitoring catalogue; on December 4, 38 species of Qianfoshan Hospital in Shandong Province were urgently listed in the auxiliary drug list, and officially stopped on December 6th... It has to be said that the auxiliary drug has become a new stage of control and control, and will face a new round of big waves. Break into the cold palace, big data makes "the god medicine" invisible Following the state's efforts to strengthen monitoring and restrict the procurement of auxiliary drugs, and the State's "Opinions on Controlling the Unreasonable Growth of Medical Expenses in Public Hospitals" were gradually implemented in various places. From the perspective of big data, Drug Intelligence Network launched drug-assisted and key monitoring. The drug database helps the country to implement the control of Antibacterial , oncology and auxiliary drugs from the perspective of data. The database contains information on “Auxiliary Drug List†or “Key Monitoring Drug List†published in various places in recent years, including drug name, region, policy documents, dosage form, dosage, release time, etc. Those “God who have been beaten into the cold house over the years†The medicine is in it. By analyzing the data of the “Shenzhen†database, it is possible to clearly understand which drugs are subject to key supervision, and how many local and institutional regulatory restrictions, to help producers, sellers, and investors to keep abreast of current policy trends, and to see the future of the pharmaceutical market. Good production, sales, investment adjustment; provide procurement and medication guidance for major medical institutions, do a good job in monitoring some drugs; provide data support for the establishment of a comprehensive system for evaluation of clinical drugs with a focus on essential drugs; effectively limit the abuse of drugs in hospitals The situation, to ease the problem of high cost of medication, difficult to see a doctor, and help patients identify the pros and cons of drugs, the first step to overcome blind drugs. Through this database, the author has compiled the TOP30 of the “Auxiliary and Key Monitoring Drug List†drugs published by provinces, cities and hospitals over the years. Among them, Danhong injection is the first, and the frequency of supervision has been up to 26 times since 2015, involving 11 provinces, cities and local medical institutions. Four drugs, such as composite coenzyme for injection and invert sugar electrolyte injection, were reported more than 20 times. It is worth noting that all the drugs listed in TOP30 were injections. Danhong injection is an injection that can activating blood circulation, removing phlegm and removing blood stasis, and is used for chest stagnation and stroke caused by blood stasis. Danhong injection in the market is mainly produced by Shandong Danhong Pharmaceutical Co., Ltd., and is included in the national medical insurance (2017 version) Class B. It is also included in the Category B medical insurance catalogue in 20 provinces and municipalities. It can be seen that Danhong injection is widely used in the market. However, due to the adverse reactions in its clinical use, its safety and effectiveness have been questioned, so it is subject to regulatory control of its use. Table: TOP30 of the drug list included in the “Auxiliary and Key Monitoring Drug List†Pharmaceutical powder raw material
Pharmaceutical powder raw material,Lenalidomide Dexamethasone, Lamivudine Intermediate for Sale,Lubiprostone for Constipation,
Xi'an Henrikang Biotech Co., Ltd., was established in May 2010, and located in Gaoling Industrial Park, Xi`an city, Shaanxi Province, China. It is a professional supplier of Healthcare Products, Vitamin And Enzyme, Human APIs , Cosmetic Raw , Veterinary Products, Food Additives , Plant Extract and natural active ingredients. It has absolute advantage because of strong research strength, modern management system and high-quality marketing team. Pharmaceutical powder raw material,Lenalidomide Dexamethasone, Lamivudine Intermediate for Sale,Lubiprostone for Constipation Xi'an Henrikang Biotech Co.,Ltd , https://www.xianhenrikangbio.com
Now we have 3 GMP standard workshop, Meanwhile, the factory is equipped with the researching and quality inspection centre, with strong technology research and development strength. We also have 3 salesdepartments over 30 people and sell our products all over the world. For customer`s needs, OEM service is also acceptable. If you have a good idea in new product production but lack of laboratory device and human resource, we are glad to solve this problem for you. Sincerely hope to strengthen exchanges and cooperation with friends from both home and abroad.